In a rare moment of global consensus, AI researchers from the US, Europe, and Asia came together in Singapore to form a plan for researching AI risks.
Categories: Nature
Nature
OpenAI and the FDA Are Holding Talks About Using AI In Drug Evaluation
High-ranking OpenAI employees have met with the FDA multiple times in recent weeks to discuss AI and a project called cderGPT.
0 Comments